Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Ingmar Hoerr

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

scientific article (publication date: November 2016)

A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer

scientific article published on 15 February 2019

A successful founder off the beaten path

scientific article published in October 2017

Characterization of the ribonuclease activity on the skin surface

scientific article

Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients

scientific article published in June 2009

Distinct transcriptional changes in non-small cell lung cancer patients associated with multi-antigenic RNActive® CV9201 immunotherapy

scientific article

In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies

scholarly article

Intradermal Vaccinations With RNA Coding for TAA Generate CD8+ and CD4+ Immune Responses and Induce Clinical Benefit in Vaccinated Patients

scientific article published on December 28, 2010

Long-term survival correlates with immunological responses in renal cell carcinoma patients treated with mRNA-based immunotherapy

scientific article published on 29 October 2015

Production and characterization of amplified tumor-derived cRNA libraries to be used as vaccines against metastatic melanomas

scientific article

Results of the first phase I/II clinical vaccination trial with direct injection of mRNA.

scientific article

Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial

scientific article published on 25 July 2017

Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study

scientific article published on 16 June 2015

Therapeutic anti-tumor immunity triggered by injections of immunostimulating single-stranded RNA.

scientific article published on October 2006

Toll-like receptor-dependent activation of several human blood cell types by protamine-condensed mRNA.

scientific article